Medical Aesthetic Devices Market Size, Share, Industry Trends and Forecast to 2033
This report analyzes the Medical Aesthetic Devices market, providing insights and predictions for the forecast period of 2023 to 2033, covering market size, trends, key players, and regional performance.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $12.00 Billion |
| CAGR (2023-2033) | 8.7% |
| 2033 Market Size | $28.40 Billion |
| Top Companies | Allergan PLC, Merz Pharmaceuticals, Galderma S.A., Hologic, Inc., Revance Therapeutics, Inc. |
| Last Modified Date | 15 Nov 2024 |
Medical Aesthetic Devices Market Report (2023 - 2033)
Medical Aesthetic Devices Market Overview
What is the Market Size & CAGR of Medical Aesthetic Devices market in 2023?
Medical Aesthetic Devices Industry Analysis
Medical Aesthetic Devices Market Segmentation and Scope
Request a custom research report for industry.
Medical Aesthetic Devices Market Analysis Report by Region
Europe Medical Aesthetic Devices Market Report:
The European market is anticipated to grow significantly, from USD 3.95 billion in 2023 to USD 9.34 billion by 2033. Europe’s strong focus on aesthetic and cosmetic procedures, combined with technological advancements, supports market expansion.Asia Pacific Medical Aesthetic Devices Market Report:
The Asia Pacific region represents a rapidly expanding market for Medical Aesthetic Devices, expected to grow from USD 2.04 billion in 2023 to USD 4.83 billion by 2033. Increased awareness of aesthetic procedures, coupled with a rising middle class and a growing emphasis on personal appearance, drives this growth.North America Medical Aesthetic Devices Market Report:
North America leads the Medical Aesthetic Devices market, projected to grow from USD 4.23 billion in 2023 to USD 10 billion by 2033. Higher disposable incomes, a robust healthcare system, and increasing demand for advanced aesthetic treatments drive this significant growth.South America Medical Aesthetic Devices Market Report:
The South American market is smaller but poised for steady growth, expanding from USD 0.29 billion in 2023 to USD 0.69 billion by 2033. Economic improvements and a growing demand for cosmetic procedures are key factors boosting this region.Middle East & Africa Medical Aesthetic Devices Market Report:
In the Middle East and Africa, the market is anticipated to grow from USD 1.50 billion in 2023 to USD 3.54 billion by 2033, driven by rising demand for aesthetic treatments and an evolving cosmetic culture.Request a custom research report for industry.
Medical Aesthetic Devices Market Analysis By Device Type
Global Medical Aesthetic Devices Market, By Device Type Market Analysis (2023 - 2033)
The breakdown of the Medical Aesthetic Devices market by device type shows strong performance across various categories. In 2023, the market value for laser devices stands at USD 7.88 billion (65.63% share), followed by energy-based devices at USD 3.32 billion (27.68% share), and injectable devices at USD 0.80 billion (6.69% share). By 2033, laser devices are expected to reach USD 18.64 billion, while the market share for energy-based devices and injectables will remain significant.
Medical Aesthetic Devices Market Analysis By Application
Global Medical Aesthetic Devices Market, By Application Market Analysis (2023 - 2033)
The application segment is led by skin rejuvenation, valued at USD 6.12 billion (50.99% share) in 2023, with a projected growth to USD 14.48 billion by 2033. Body contouring and hair removal also contribute with USD 2.88 billion (24.03% share) and USD 1.43 billion (11.92% share), respectively. Notably, tattoo removal holds a market of USD 1.57 billion (13.06% share), showcasing diversified consumer preferences for aesthetic treatments.
Medical Aesthetic Devices Market Analysis By End User
Global Medical Aesthetic Devices Market, By End-User Market Analysis (2023 - 2033)
Clinics dominate the end-user market, with a size of USD 7.88 billion (65.63% share) in 2023, reaching USD 18.64 billion by 2033. Hospitals follow with USD 3.32 billion (27.68% share) projected to increase to USD 7.86 billion and home-use devices at USD 0.80 billion (6.69% share) to USD 1.90 billion, showing the increasing trend towards at-home aesthetic solutions.
Medical Aesthetic Devices Market Analysis By Technology
Global Medical Aesthetic Devices Market, By Technology Market Analysis (2023 - 2033)
Non-invasive technology leads the market with a size of USD 9.76 billion (81.33% share) in 2023 and is expected to surge to USD 23.10 billion by 2033. Minimally-invasive technology holds a market size of USD 2.24 billion (18.67% share), projected to reach USD 5.30 billion. This highlights a consumer preference for less invasive procedures while still seeking effective results.
Medical Aesthetic Devices Market Analysis By Distribution Channel
Global Medical Aesthetic Devices Market, By Distribution Channel Market Analysis (2023 - 2033)
The distribution channel analysis reveals that direct sales currently hold a leading market size of USD 7.88 billion (65.63% share) in 2023, projected to double to USD 18.64 billion by 2033. Online sales also show significant growth from USD 3.32 billion (27.68% share) to USD 7.86 billion, reflecting a shift towards digital purchasing behaviors. Third-party distributors maintain a modest presence with USD 0.80 billion (6.69% share).
Medical Aesthetic Devices Market Trends and Future Forecast
Request a custom research report for industry.
Global Market Leaders and Top Companies in Medical Aesthetic Devices Industry
Allergan PLC:
Allergan is a leading global pharmaceutical company known for its innovative medical aesthetic products, particularly its Botox and dermal filler offerings, which dominate the injectable market segment.Merz Pharmaceuticals:
Merz is recognized for its diverse range of aesthetic devices, including injectables and energy-based devices, playing a significant role in shaping non-invasive and minimally invasive treatment options.Galderma S.A.:
Galderma specializes in dermatological products with a strong emphasis on aesthetic treatments, offering a range of fillers and rejuvenation technologies used globally.Hologic, Inc.:
Hologic is a leader in women's health devices, focusing on breast aesthetics and body contouring solutions, contributing significantly to the market's growth.Revance Therapeutics, Inc.:
Revance is emerging as a key player with its innovative DaxibotulinumtoxinA injection, which presents a competitive alternative to traditional botulinum toxin products.We're grateful to work with incredible clients.
